Global Aripiprazole Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Aripiprazole Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism.
Aripiprazole Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aripiprazole Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adult Patients and Pediatric Patients are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aripiprazole Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Aripiprazole Drug key manufacturers include Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, Alembic Pharmaceuticals, Orchid Pharma, Amneal and Aurobindo Pharma, etc. Otsuka Pharmaceutical, Teva, APOTEX are top 3 players and held % sales share in total in 2022.
Aripiprazole Drug can be divided into Tablets, Orally Disintegrating Tablets, Oral Solution and Injection, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Aripiprazole Drug is widely used in various fields, such as Adult Patients and Pediatric Patients, etc. Adult Patients provides greatest supports to the Aripiprazole Drug industry development. In 2022, global % sales of Aripiprazole Drug went into Adult Patients filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aripiprazole Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett
Segment by Type
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Adult Patients
Pediatric Patients
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Aripiprazole Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aripiprazole Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aripiprazole Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aripiprazole Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aripiprazole Drug introduction, etc. Aripiprazole Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Aripiprazole Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Aripiprazole Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aripiprazole Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adult Patients and Pediatric Patients are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aripiprazole Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Aripiprazole Drug key manufacturers include Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, Alembic Pharmaceuticals, Orchid Pharma, Amneal and Aurobindo Pharma, etc. Otsuka Pharmaceutical, Teva, APOTEX are top 3 players and held % sales share in total in 2022.
Aripiprazole Drug can be divided into Tablets, Orally Disintegrating Tablets, Oral Solution and Injection, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Aripiprazole Drug is widely used in various fields, such as Adult Patients and Pediatric Patients, etc. Adult Patients provides greatest supports to the Aripiprazole Drug industry development. In 2022, global % sales of Aripiprazole Drug went into Adult Patients filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aripiprazole Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett
Segment by Type
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Segment by Application
Adult Patients
Pediatric Patients
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Aripiprazole Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aripiprazole Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aripiprazole Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aripiprazole Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aripiprazole Drug introduction, etc. Aripiprazole Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Aripiprazole Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
